Home » Irish Pharma in E40 Million U.S. Placement
Irish Pharma in E40 Million U.S. Placement
June 8, 2005
Azur Pharma, the biotech firm headed by former Elan executive, Seamus Mulligan, said it has successfully completed a private placement of equity securities worth E40 million. Azur Pharma was founded in March of this year with the aim of, through selective acquisitions, to build a portfolio of established pharmaceutical brands and enhance their value through focused sales and marketing activities and the application of drug delivery technologies.
()a href="http://www.businessworld.ie/livenews.htm?a=1187965;s=rollingnews.htm" target="_blank">Business World
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct